Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data (RWD), today announced the renewal of its collaboration with the National ...

N-Power Medicine has successfully secured $32 million in a Series B financing round, a significant milestone that will ...

Novavax (NASDAQ:NVAX) outlined its strategy to expand the use of its Matrix-M adjuvant platform through licensing partnerships, internal research programs and commercialization alliances, with managem ...

Oncology nurses have played a vital role in research since the founding of Fred Hutch Cancer Center more than 50 years ago, writing the policy and procedure manuals for nurses treating the very first ...

Tumors are good at adapting. They lose the markers that targeted therapies are built to find, evolve resistance to drugs designed to kill them, and build a hostile environment that neutralizes immune ...

Multi-phase initiative will generate single cell and spatial data from over 20,000 samples across leading immuno-oncology laboratories to map the immune landscape of cancer and drive the next ...

Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roof for the ...

Genentech will close its cancer immunology research department, and unit head and renowned cell biologist Ira Mellman, who has been with the company for 17 years, will depart in the coming months. The ...

St. Louis Children’s Hospital is growing its research efforts to find a cure for pediatric cancer.

Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roof for the ...